Iris Hybrid
Hybrid Glucose Monitoring
Iris Hybrid
This glucometer integrates all the technology of the continuous glycemic monitoring system with artificial intelligence to support the patient and to guide him to an unparalleled therapeutic adherence experience.
It is always connected to IRIS HEALTH CARE, the telemedicine platform of Alpha Pharma Service and Emtesys which is equipped with a control room, the beating heart of all our telemedicine systems. At each measurement, Iris Hybryd sends the data to the platform and receives feedback based on the therapeutic indications of the specialist doctor without resorting to a smartphone application, thus increasing privacy and security.
Sempre sotto controllo
Il glucometro Iris Hybrid, in base ai risultati delle misurazioni e alle indicazioni terapeutiche dello specialista è in grado di svolgere un ruolo da vero assistente virtuale per allineare il paziente all’osservanza della corretta terapia prescritta dal medico tramite invio di notifiche personalizzate.
Iris Hybrid calcola ed evidenzia l’indice giornaliero di rischio di iper e/o ipoglicemia (l’ADRR, l’Average Daily Risk Range), l’indice di gestione della glicemia (il GMI, il Glucose Management Indicator), i valori medi ed i coefficienti di variazione della glicemia a 7 | 14 | 30 | 90 giorni e il Time In Range (TIR), l’intervallo di tempo dentro il quale i valori della glicemia rimangono nella norma.
Thanks to the electronic diary, Iris Hybrid is able to store more than 500 measurements with date and time.
Artificial intelligence
Serving patient’s well-being.
Thanks to a highly advanced system of sending and receiving information, Iris Hybrid is able to support the patient with personalized notifications based on his therapeutic plan (dictated by the specialist) and the results of his measurements.
This means greater therapeutic adherence, therefore less risk of incorrect therapy intake and greater prolonged well-being.
TELEMEDICINE: REAL TIME MANAGEMENT OF THE RESULTS
The IRIS HEALTH CARE platform is able to calculate and report the Average Daily Risk Range (ADRR), the daily index that predicts the risk of hyper and / or hypoglycaemia.
DIABETES MANAGEMENT BECOMES MORE EFFECTIVE
Using IRIS HEALTH CARE the doctor has the possibility to monitor the measurements in real time, verify – and eventually correct – the therapy and send personalized messages to the patient. The pharmacist can make pharmacist-diabetic mediation immediate. The caregiver can assist the patient more effectively.
Caratteristiche Tecniche
| wdt_ID | Caratteristica | Valori |
|---|---|---|
| 2 | Intervallo di misura | Da 10 a 600 mg/dL (0.6-33.3 mmol/L) |
| 3 | Calibrazione | Plasma-equivalente |
| 4 | Campione | Sangue intero fresco (capillare, venoso, arterioso) |
| 5 | Principio | Metodo ottico e immunodosaggio |
| 6 | Intervallo di Misurazione | 4-15% (20-140 mmol/mol) |
| 7 | Intervallo Emoglobina | 7-23 g/dl |
| 8 | HTC | 25-65% |
| 9 | Temperatura di Operatività | 15-32°C (59°F-90°F) |
| 10 | Temperatura di Conservazione | 1-30°C (34°F-86°F) |
| 11 | Unità di misura | mg/dL |
Area Download
Informativa resa ai sensi degli articoli 13-14 del GDPR 2016/67